Abstract

Idiopathic fertility disorders are associated with mutations in various genes. Here, we report that coiled-coil glutamate-rich protein 1 (CCER1), a germline-specific and intrinsically disordered protein (IDP), mediates postmeiotic spermatid differentiation. In contrast, CCER1 deficiency results in defective sperm chromatin compaction and infertility in mice. CCER1 increases transition protein (Tnp1/2) and protamine (Prm1/2) transcription and mediates multiple histone epigenetic modifications during the histone-to-protamine (HTP) transition. Immiscible with heterochromatin in the nucleus, CCER1 self-assembles into a polymer droplet and forms a liquid-liquid phase-separated condensate in the nucleus. Notably, we identified loss-of-function (LoF) variants of human CCER1 (hCCER1) in five patients with nonobstructive azoospermia (NOA) that were absent in 2713 fertile controls. The mutants led to premature termination or frameshift in CCER1 translation, and disrupted condensates in vitro. In conclusion, we propose that nuclear CCER1 is a phase-separated condensate that links histone epigenetic modifications, HTP transitions, chromatin condensation, and male fertility.

Here the authors reveal that phase‐separated nuclear CCER1 condensates are required for male fertility by mediating chromatin condensation and histone epigenetic modification, while loss‐of‐function variants of human CCER1 are pathogenic in patients with nonobstructive azoospermia (NOA).

Details

Title
Phase-separated CCER1 coordinates the histone-to-protamine transition and male fertility
Author
Qin, Dongdong 1 ; Gu, Yayun 2 ; Zhang, Yu 3 ; Wang, Shu 1 ; Jiang, Tao 2 ; Wang, Yao 4 ; Wang, Cheng 2   VIAFID ORCID Logo  ; Chen, Chang 1 ; Zhang, Tao 1 ; Xu, Weiya 1   VIAFID ORCID Logo  ; Wang, Hanben 1 ; Zhang, Ke 4 ; Hu, Liangjun 4 ; Li, Lufan 1 ; Xie, Wei 4   VIAFID ORCID Logo  ; Wu, Xin 1   VIAFID ORCID Logo  ; Hu, Zhibin 2   VIAFID ORCID Logo 

 Nanjing Medical University, State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
 Nanjing Medical University, State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984); Nanjing Medical University, School of Public Health, Center for Global Health, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
 Tsinghua University, Center for Stem Cell Biology and Regenerative Medicine, MOE Key Laboratory of Bioinformatics, School of Life Sciences, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178); Tsinghua-Peking Center for Life Sciences, Beijing, China (GRID:grid.452723.5) (ISNI:0000 0004 7887 9190); Fudan University, Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Chinese Academy of Medical Sciences, Research Units of Embryo Original Diseases, Shanghai, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 Tsinghua University, Center for Stem Cell Biology and Regenerative Medicine, MOE Key Laboratory of Bioinformatics, School of Life Sciences, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178); Tsinghua-Peking Center for Life Sciences, Beijing, China (GRID:grid.452723.5) (ISNI:0000 0004 7887 9190) 
Pages
8209
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2900471990
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.